---
document_datetime: 2023-09-21 18:35:40
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/avandamet-epar-all-authorised-presentations_en.pdf
document_name: avandamet-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.3906905
conversion_datetime: 2025-12-25 05:07:03.36586
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength     | Pharmaceutical Form   | Route of administration   | Packaging              |   Package size |
|-----------------|-----------------|--------------|-----------------------|---------------------------|------------------------|----------------|
| EU/1/03/258/001 | Avandamet       | 1 mg/500 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             28 |
| EU/1/03/258/002 | Avandamet       | 1 mg/500 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             56 |
| EU/1/03/258/003 | Avandamet       | 1 mg/500 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            112 |
| EU/1/03/258/004 | Avandamet       | 2 mg/500 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             28 |
| EU/1/03/258/005 | Avandamet       | 2 mg/500 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             56 |
| EU/1/03/258/006 | Avandamet       | 2 mg/500 mg  | Film-coated tablet    | longer Oral use           | blister (PVC/PVDC/alu) |            112 |
| EU/1/03/258/007 | Avandamet       | 2 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             14 |
| EU/1/03/258/008 | Avandamet       | 2 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             28 |
| EU/1/03/258/009 | Avandamet       | 2 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             56 |
| EU/1/03/258/010 | Avandamet       | 4 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             14 |
| EU/1/03/258/011 | Avandamet       | 4 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             28 |
| EU/1/03/258/012 | Avandamet       | 4 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |             56 |
| EU/1/03/258/013 | Avandamet       | 2 mg/1000 mg | no Film-coated tablet | Oral use                  | blister (PVC/PVDC/alu) |            112 |
| EU/1/03/258/014 | Avandamet       | 4 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            112 |
| EU/1/03/258/015 | Avandamet       | 1 mg/500 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            336 |
| EU/1/03/258/016 | Avandamet       | 2 mg/500 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            336 |
| EU/1/03/258/017 | Avandamet       | 2 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            168 |
| EU/1/03/258/018 | Avandamet       | 4 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            168 |
| EU/1/03/258/019 | Avandamet       | 1 mg/500 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            360 |
| EU/1/03/258/020 | Avandamet       | 2 mg/500 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            360 |
| EU/1/03/258/021 | Avandamet       | 2 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            180 |
| EU/1/03/258/022 | Avandamet       | 4 mg/1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) |            180 |

Medicinal product no longer authorised 1/1